There was no association between the presence of TGFBR3 and P-FSH (median 5.0 IU/L (IQR 2.7–8.5) and median 5.7 (IQR 2.3–8.9) in TGFBR3 negative and positive tumours, respectively, p = 0.80) or P-LH (median 2.1 IU/L (IQR1.1-3.6) and median 2.9 (IQR 1.0-4.6) in TGFBR3 negative and positive tumours, respectively, p = 0.70). The gene discussed is BRD2; the disease is neoplasm.